Anti-Carboxypeptidase A antibody [EPR24384-69],Abcam,AB278044

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Host

Rabbit

Reactivity

Human, Mouse, Rat

Application

mIHC, ICC/IF, IHC-P, WB, IHC-Fr

Platform ID

BAB301810677

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameAnti-Carboxypeptidase A antibody [EPR24384-69]
Cat. No.AB278044
HostRabbit
IsotypeIgG
ReactivityHuman, Mouse, Rat
ApplicationmIHC, ICC/IF, IHC-P, WB, IHC-Fr
ClonalityMonoclonal
Clone NumberEPR24384-69
Concentration0.539 mg/mL Batch dependent concentration
ImmunogenThe exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Protein A
Appearance/FormLiquid
ShippingBlue Ice
FormulationPreservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data Carboxypeptidase that catalyzes the release of a C-terminal amino acid, but has little or no action with -Asp, -Glu, -Arg, -Lys or -Pro (PubMed : 20385563, PubMed : 8806703). Catalyzes the conversion of leukotriene C4 to leukotriene F4 via the hydrolysis of an amide bond (By similarity). See full target information CPA1

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.